UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): June 29 30, 2006

VIRBAC CORPORATION

(Exact Name of Registrant as Specified in Charter)

Delaware		0-24312		43-1648680
(State of Incorporation)		(Commission File No.)		(IRS Employer Identification No.)


Delaware (State of Incorporation)		0-24312 (Commission File No.)		43-1648680 (IRS Employer Identification No.)

3200 Meacham Boulevard
Fort Worth, Texas 76137
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (817) 831-5030

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 71.01 ~~Regulation FD~~Entry ~~Disclosure~~into ~~and Item 8.01~~a ~~Other~~Material ~~Events~~Definitive Agreement

On June 29, 2006, Virbac Corporation, ~~issued~~PM aResources, ~~press~~Inc., ~~release~~St. ~~announcing~~JON ~~that~~Laboratories, ~~its~~Inc., ~~settlement~~Francodex Laboratories, ~~with~~Inc., ~~the U~~Virbac AH, Inc.S, and Delmarva Laboratories, Inc., ~~Securities~~(the ~~and~~“Borrowers”) ~~Exchange~~entered into ~~Commission~~an ~~has~~Amendment ~~been~~Letter ~~finalized.~~regarding Athe ~~copy~~Execution of ~~the~~Syndicated ~~press~~Loan ~~release~~Documents (“Amendment Letter”) iswith ~~attached~~First ~~hereto~~Bank, asa ~~Exhibit 99~~Missouri banking corporation (the “Lender”).1 The Amendment Letter extends the June 30, 2006 deadline date requiring the Borrowers to execute a new amended and ~~incorporated~~restated ~~herein~~loan agreement byand ~~reference~~other documents set forth in Paragraph 8 of the Ninth Amendment to Credit Agreement to July 31, 2006.

Item 9.01 Financial Statements and Exhibits

(dc) Exhibits.

99.1 Press release of the Company, dated June 29, 2006

	10.1		Ninth Amendment to Credit Agreement by and among Virbac Corporation, PM Resources, Inc., St. JON Laboratories, Inc., Francodex Laboratories, Inc., Virbac AH, Inc., Delmarva Laboratories, Inc., and First Bank, dated March 24, 2006, incorporated herein by reference to the Company’s Annual Report on Form 10-K for the annual period ended December 31, 2005 (File No. 000-24312).

	10.2		Amendment re Execution of Syndicated Loan Documents dated June 29, 2006.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	VIRBAC CORPORATION
Date: June 29, 2006	By:	/s/ Jean M. Nelson
Date: July 7, 2006	By:	/s/ Jean M. Nelson
		Jean M. Nelson
		Executive Vice-President and Chief Financial Officer

EXHIBIT INDEX

Exhibit No.				Description
99.1				Press release of the Company, dated June 29, 2006

Filing Compare · VIRBAC CORP